Black market medicine distributors have impacted patient health in many areas. We examined two different therapeutic areas of non-FDA approved medication infiltrating the secure U.S. drug supply chain.
Learn more about the prescription drug black market and what policy makers, medical professionals, patients and consumers can do to protect the secure U.S. drug supply chain.
Black Market Cancer Drug Cases 2007-2013 examines the problem of illicit/counterfeit injectable cancer medications making their way into U.S. doctors’ offices.
Black Market IUD Cases 2009-2013 reviews the disturbing trend toward importation and use of non-FDA approved IUDs by practictioners.
Click here for more counterfeit drug resources and information aimed at policy makers.